FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma

Clinical trial NCT04393584 · UNKNOWN

Trial details

NCT number: NCT04393584
Sponsor: Blokhin's Russian Cancer Research Center
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Stomach Neoplasms Gastrointestinal Neoplasms Docetaxel Oxaliplatin Fluoruracil Irinotecan Hydrochloride

Start date: 2019-01-29
Primary completion: 2024-01-01
Enrollment: 538

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.